Pharmaceuticals, Biotechnology and Life Sciences
Houston, TX, Nov. 18, 2021 (GLOBE NEWSWIRE) — RadioMedix, a clinical-stage biotechnology company developing radiotheranostic drugs, announced that it has…
MISSISSAUGA, Ontario, Nov. 18, 2021 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for…
–– 58 of the original 59 subjects continue in the open-label extension portion of the Phase 2 trial. –– Phase…
GUANGZHOU, China, Nov. 17, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today…
· Reauthorization of EUA expands beyond initial qualitative detection claim · CEO to appear on Cheddar News at 6:10pm tonight, November 17th,…
DAVIS, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection…
NEWARK, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing…
Call to be held on Monday, November 22nd at 10:00am ET BASKING RIDGE, NJ, Nov. 17, 2021 (GLOBE NEWSWIRE) —…
Wholly-owned pipeline with three clinical-stage programs targeting significant inflammatory and immunology disease markets Dosing initiated in a multiple-ascending dose (MAD)…
SEATTLE, Nov. 17, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development…